Acute Porphyria Drugs

Risk unknown, avoid. Use a safe alternative.
In a life threatening emergency, do not withhold any critically required medication.
In an emergency do not delay, however if time permits, find a safe alternative.
Discuss with an expert porphyria service if available.
Assess risk vs. benefit
Highest risk in patients with
  • Recurrent attacks
  • Recent attacks
  • Other triggers present, e.g. fasting, alcohol, multiple medications
  • Females of reproductive age
Lower risk in patients with
  • Asymptomatic acute porphyria
  • Latent acute porphyria
(Note that low risk doesn't mean no risk)
Expected benefit from treatment?
If benefit strongly outweighs risk, treat but take precautions
Counsel patient
  • On risk vs. benefits
  • To avoid other triggers: fasting, alcohol, recreational drugs.
  • Regarding acute attack symptoms like severe abdominal/back/leg pain and, possibly behavioural change; this may be accompanied by nausea, vomiting, constipation, but these are also known adverse drug effects.
  • On actions to take if symptoms were to develop.
Prepare
  • Measure baseline urine porphobilinogen (PBG), since baseline concentrations may be elevated.
  • Establish availability of haemin to treat a potential future attack.
  • Inform all healthcare professionals involved in patient’s care.
Manage
  • If symptoms develop, stop drug and repeat urine PBG urgently, and compare to baseline for interpretation.
  • Manage confirmed acute attacks.

In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙